[{"address1": "Maxim 1", "address2": "2 Parklands Way Holytown", "city": "Motherwell", "zip": "ML1 4WR", "country": "United Kingdom", "phone": "44 14 1433 7557", "website": "https://tcbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bryan Leland Kobel", "age": 45, "title": "CEO & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 544560, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Martin Edward Thorp", "age": 72, "title": "CFO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 410521, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Camarra", "title": "Executive Vice President of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lauren  Bor Ph.D.", "title": "Head of Commercial Development Division", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.54, "open": 1.51, "dayLow": 0.5, "dayHigh": 1.54, "regularMarketPreviousClose": 1.54, "regularMarketOpen": 1.51, "regularMarketDayLow": 0.5, "regularMarketDayHigh": 1.54, "payoutRatio": 0.0, "beta": 0.012, "forwardPE": -0.108695656, "volume": 4267082, "regularMarketVolume": 4267082, "averageVolume": 362098, "averageVolume10days": 731990, "averageDailyVolume10Day": 731990, "bid": 0.3689, "ask": 0.6448, "bidSize": 2, "askSize": 2, "marketCap": 256496, "fiftyTwoWeekLow": 0.5, "fiftyTwoWeekHigh": 523.2, "fiftyDayAverage": 4.1108, "twoHundredDayAverage": 57.5845, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 50101200, "profitMargins": 0.0, "floatShares": 98869384, "sharesOutstanding": 512992, "sharesShort": 49374, "sharesShortPriorMonth": 3838, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0962, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.0070499997, "shortRatio": 0.11, "shortPercentOfFloat": 0.1022, "impliedSharesOutstanding": 3195130, "bookValue": 81.056, "priceToBook": 0.006168575, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -11573336, "trailingEps": -4828.57, "forwardEps": -4.6, "lastSplitFactor": "1:20", "lastSplitDate": 1739145600, "enterpriseToEbitda": -4.423, "52WeekChange": -0.99782985, "SandP52WeekChange": 0.086116076, "quoteType": "EQUITY", "currentPrice": 0.5, "targetHighPrice": 48.0, "targetLowPrice": 48.0, "targetMeanPrice": 48.0, "targetMedianPrice": 48.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1004329, "totalCashPerShare": 0.01, "ebitda": -11327400, "totalDebt": 1653527, "quickRatio": 0.642, "currentRatio": 1.12, "debtToEquity": 82.504, "returnOnAssets": -0.98203003, "returnOnEquity": -5.77043, "freeCashflow": -6030418, "operatingCashflow": -8837196, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "GBP", "symbol": "TCBP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "TC BioPharm (Holdings) plc", "marketState": "CLOSED", "longName": "TC Biopharm (Holdings) Plc", "regularMarketChangePercent": -67.53247, "regularMarketPrice": 0.5, "exchange": "NCM", "messageBoardId": "finmb_1681274131", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [{"header": "Delisting", "message": "TCBP is delisted effective Mar. 24, 2025", "meta": {"eventType": "DELISTING", "dateEpochMs": 1742788800000}}], "postMarketTime": 1742601595, "regularMarketTime": 1742587200, "epsTrailingTwelveMonths": -4828.57, "epsForward": -4.6, "fiftyDayAverageChange": -3.6107998, "fiftyDayAverageChangePercent": -0.87836915, "twoHundredDayAverageChange": -57.0845, "twoHundredDayAverageChangePercent": -0.9913171, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-11", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1644589800000, "postMarketChangePercent": 34.02, "postMarketPrice": 0.6701, "postMarketChange": 0.1701, "regularMarketChange": -1.04, "regularMarketDayRange": "0.5 - 1.54", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 362098, "fiftyTwoWeekLowChange": 0.0, "fiftyTwoWeekLowChangePercent": 0.0, "fiftyTwoWeekRange": "0.5 - 523.2", "fiftyTwoWeekHighChange": -522.7, "fiftyTwoWeekHighChangePercent": -0.99904436, "fiftyTwoWeekChangePercent": -99.78298, "displayName": "TC Biopharm (Holdings)", "trailingPegRatio": null, "__fetch_time": "2025-03-22"}]